Hidradenitis suppurativa in sexual and gender minorities: A review and considerations for providers.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 35283243.
- Also identified by DOI 10.1016/j.jaad.2022.03.008.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The literature on hidradenitis suppurativa in sexual and gender minorities remains sparse. This review article aims to discuss critical factors for providers to consider in lesbian, gay, bisexual, transgender, queer, intersex, and asexual patients with hidradenitis suppurativa, including associated comorbidities, gender-affirming hormonal therapy, squamous cell carcinoma, infections in HIV-positive patients, and creating a welcoming clinic for sexual and gender minority patients.
Medical subject headings
- Hidradenitis Suppurativa
- Sexual and Gender Minorities
- Transgender Persons
- Homosexuality, Female